(MRZM) – Globe Newswire
-
Marizyme Announces IP Developments for DuraGraft® and Its Pipeline Products
-
Statera Biopharma Announces Changes to Board of Directors
-
Marizyme Announces Allowance of Patent Application for Flagship Product DuraGraft by United States Patent and Trademark Office
-
Marizyme Announces the Closing of My Health Logic Acquisition Along With Initial Financing
-
Marizyme Inc. Announces Results of GOAL Study Presented at 7th Annual International Coronary Congress
-
Marizyme Announces Expansion of Patent Portfolio Into Several Key Territories
-
Marizyme is Pleased to Announce the Appointment of David Barthel as CEO
-
Univest Securities, LLC. Announces Closing of Somulation, Inc. Acquisition and $7 Million Private Placement for its Client Marizyme, Inc. (OTC: MRZM)
Back to MRZM Stock Lookup